223 related articles for article (PubMed ID: 27063186)
1. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.
Gigante M; Pontrelli P; Herr W; Gigante M; D'Avenia M; Zaza G; Cavalcanti E; Accetturo M; Lucarelli G; Carrieri G; Battaglia M; Storkus WJ; Gesualdo L; Ranieri E
J Transl Med; 2016 Apr; 14():84. PubMed ID: 27063186
[TBL] [Abstract][Full Text] [Related]
2. JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients.
Cavalcanti E; Gigante M; Mancini V; Battaglia M; Ditonno P; Capobianco C; Cincione RI; Selvaggi FP; Herr W; Storkus WJ; Gesualdo L; Ranieri E
J Biomed Biotechnol; 2010; 2010():935764. PubMed ID: 20339477
[TBL] [Abstract][Full Text] [Related]
3. Expression and functional role of miR-29b in renal cell carcinoma.
Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
[TBL] [Abstract][Full Text] [Related]
4. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
5. JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.
Liang F; Liang H; Li Z; Huang P
Int Immunopharmacol; 2020 Sep; 86():106706. PubMed ID: 32570038
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial effects of miR-20a and miR-29b on neuronal apoptosis induced by spinal cord injury.
Liu XJ; Zheng XP; Zhang R; Guo YL; Wang JH
Int J Clin Exp Pathol; 2015; 8(4):3811-8. PubMed ID: 26097563
[TBL] [Abstract][Full Text] [Related]
7. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
Zhu S; Huang Y; Su X
Med Sci Monit; 2016 Jan; 22():183-90. PubMed ID: 26779781
[TBL] [Abstract][Full Text] [Related]
8. MCL-1 is modulated in Crohn's disease fibrosis by miR-29b via IL-6 and IL-8.
Nijhuis A; Curciarello R; Mehta S; Feakins R; Bishop CL; Lindsay JO; Silver A
Cell Tissue Res; 2017 May; 368(2):325-335. PubMed ID: 28190086
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
12. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
[TBL] [Abstract][Full Text] [Related]
13. MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
Xiao W; Wang C; Chen K; Wang T; Xing J; Zhang X; Wang X
EBioMedicine; 2020 Jan; 51():102622. PubMed ID: 31901870
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
[No Abstract] [Full Text] [Related]
15. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.
Zhang T; Zou P; Wang T; Xiang J; Cheng J; Chen D; Zhou J
Tumour Biol; 2016 Jul; 37(7):8931-40. PubMed ID: 26753959
[TBL] [Abstract][Full Text] [Related]
16. Effect of miR-29b on the Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle Cells by Targeting Mcl-1 and CCND2.
Chen J; Li Y; Li Y; Xie L; Wang J; Zhang Y; Xiao T
Biomed Res Int; 2018; 2018():6051407. PubMed ID: 29662889
[TBL] [Abstract][Full Text] [Related]
17. BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer.
Sugio A; Iwasaki M; Habata S; Mariya T; Suzuki M; Osogami H; Tamate M; Tanaka R; Saito T
Gynecol Oncol; 2014 Sep; 134(3):615-23. PubMed ID: 24992675
[TBL] [Abstract][Full Text] [Related]
18. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
[TBL] [Abstract][Full Text] [Related]
19. MiR-23b functions as an oncogenic miRNA by downregulating Mcl-1S in lung cancer cell line A549.
Wang L; Hu Z; Guo Q; Yang L; Pang Y; Wang W
J Biochem Mol Toxicol; 2020 Jul; 34(7):e22494. PubMed ID: 32281274
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia.
Kirimura S; Kurata M; Nakagawa Y; Onishi I; Abe-Suzuki S; Abe S; Yamamoto K; Kitagawa M
Pathology; 2016 Apr; 48(3):233-41. PubMed ID: 27020498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
